Four commercial and regulatory partnerships spanning pharmaceutical distribution, working capital, chronic disease management, and digital compliance were announced in Kigali on Tuesday, highlighting an increasing focus on private-sector channels to address healthcare bottlenecks across Sub-Saharan Africa.
The deals were unveiled at the fourth annual Access to Markets (A2M) conference, held alongside the Africa HealthTech Summit in the Rwandan capital. Convened by Investing in Innovation Africa (i3) — a pan-African initiative funded by the Gates Foundation alongside pharmaceutical and logistics sponsors including MSD, Cencora, Sanofi, and Boehringer Ingelheim — the event brought together 20 African healthtech companies and 57 international and regional institutions.
The agreements reflect a broader shift among global health sponsors and private investors toward scaling commercially viable models rather than relying solely on traditional grant funding.
Financing frontline distribution
Pharmaceutical supply chains in Sub-Saharan Africa remain heavily fragmented, with small retail pharmacies and drug shops bearing the primary burden of last-mile medicine delivery. However, limited access to working capital frequently leads to inventory stock-outs and volatile pricing for essential drugs.
To address cash-flow constraints among retail vendors, Tanzanian healthtech firm Dawa Mkononi signed an agreement with NMB Bank to expand interest-free credit lines to pharmacies, drug shops, and health facilities across Tanzania. The financing model relies on Dawa Mkononi’s proprietary credit-scoring engine, which has previously underwritten over $6 million in credit to frontline facilities while maintaining a non-performing loan (NPL) rate of 0.3 per cent.
Separately, French-African healthtech startup Meditect secured debt financing from German biopharmaceutical group Boehringer Ingelheim. Meditect provides cloud-based enterprise software to retail pharmacies across Francophone Africa, integrating inventory management with digitised supply chains to combat the proliferation of counterfeit and substandard medicines.
“Everyone deserves access to safe, high-quality medicines, irrespective of where you live,” said Aditya Peri, Associate Director at Boehringer Ingelheim. “By strengthening trusted pharmaceutical supply chains and helping patients access authentic medicines, Meditect is playing a critical role in tackling the widespread challenge of counterfeit and substandard medicines across the region.”
Re-engineering chronic disease care
Beyond wholesale distribution, African healthtech firms are increasingly stepping into primary care delivery, driven by a rapid rise in non-communicable diseases (NCDs) such as hypertension and diabetes across the continent.
Kenya-based digital pharmacy platform MYDAWA announced a joint initiative with US-based Endless Health and healthcare innovation center Ariadne Labs to design and test a digital-first chronic care delivery model for low- and middle-income patients in East Africa. The pilot aims to generate clinical and operational data evaluating whether private pharmacy networks can serve as standardized, high-quality nodes for ongoing disease management. In parallel, MYDAWA is integrating WhatsApp-based communications through software provider Turn.io to automate patient engagement.
“Chronic disease care in East Africa is being delivered through private pharmacies whether the system plans for it or not,” said Rubayat Khan, Director of Health Programs at Endless Health. “What is missing is evidence about whether that channel can deliver quality, not just convenience.”
Priscilla Muhiu, Group Chief Operating Officer at MYDAWA, noted that community pharmacies are frequently the initial point of contact for patients. “This partnership gives us an opportunity to make access more affordable and strengthen care delivery for patients in their own communities,” Muhiu said.
Digital regulation and enforcement
As digital pharmacies and online drug sales expand across Africa, national regulators face growing operational strain in maintaining safety standards and tracking distribution networks.
Addressing regulatory enforcement, technology provider Sproxil signed a Memorandum of Collaboration with the Pharmacy Council of Nigeria (PCN). Under the agreement, Sproxil will supply technical and data infrastructure to support Nigeria’s National Electronic Pharmacy Platform, digitize PCN’s field audit processes, and monitor online pharmaceutical sales. Regulatory authority will remain strictly with the PCN.
The initiative builds on Sproxil’s existing authentication platforms and AI-driven market surveillance tools, which target counterfeit drugs in West Africa.
Market maturity and metrics
The i3 program, implemented by health consulting firms Salient Advisory and the Solina Centre for International Development and Research (SCIDaR), was established to bridge the gap between early-stage healthcare startups and institutional capital or commercial partners.
According to figures released by i3, the program has facilitated over 760 targeted introductions over the past six years, yielding 165 commercial partnerships, pilot projects, and Memorandums of Understanding with a combined value exceeding $19 million. Participating companies have supplied or tracked over 209 million health products across 19 countries, reaching an estimated 6.85 million patients as of April 2026.
“African innovators are reshaping healthcare delivery across the region, with solutions designed to address local gaps and reach the communities and patients who need them most,” said Oladunni Lawal, Investing in Innovation Lead. “Through Access to Markets, we are bringing regional and global partners closer to these businesses, opening commercial opportunities that enable their innovations to deliver greater health impact.”
With international forums such as the UN General Assembly placing renewed emphasis on health system resilience and sustainable funding models, the Kigali deals suggest that commercial distribution networks and hybrid public-private technology partnerships are likely to play a central role in the future of African healthcare delivery.